Evaluation of Synergetic Anticancer Activity of Berberine and Curcumin on Different Models of A549, Hep-G2, MCF-7, Jurkat, and K562 Cell Lines.
Balakrishna, Acharya
Evaluation of Synergetic Anticancer Activity of Berberine and Curcumin on Different Models of A549, Hep-G2, MCF-7, Jurkat, and K562 Cell Lines. [electronic resource] - BioMed research international 2015 - 354614 p. digital
Publication Type: Comparative Study; Journal Article
2314-6141
10.1155/2015/354614 doi
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Berberine--administration & dosage
Cell Survival--drug effects
Curcumin--administration & dosage
Dose-Response Relationship, Drug
Drug Synergism
Hep G2 Cells
Humans
Jurkat Cells
K562 Cells
MCF-7 Cells
Neoplasms, Experimental--drug therapy
Treatment Outcome
Evaluation of Synergetic Anticancer Activity of Berberine and Curcumin on Different Models of A549, Hep-G2, MCF-7, Jurkat, and K562 Cell Lines. [electronic resource] - BioMed research international 2015 - 354614 p. digital
Publication Type: Comparative Study; Journal Article
2314-6141
10.1155/2015/354614 doi
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Berberine--administration & dosage
Cell Survival--drug effects
Curcumin--administration & dosage
Dose-Response Relationship, Drug
Drug Synergism
Hep G2 Cells
Humans
Jurkat Cells
K562 Cells
MCF-7 Cells
Neoplasms, Experimental--drug therapy
Treatment Outcome